| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMO | Common Stock | Options Exercise | $2,103,400 | +20,000 | +110% | $105.17 | 38,134 | 14 May 2024 | Direct | |
| transaction | TMO | Common Stock | Sale | $11,801,000 | -20,000 | -52% | $590.05 | 18,134 | 14 May 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMO | Stock Option (Right to Buy) | Options Exercise | $0 | -20,000 | -14% | $0.000000 | 122,637 | 14 May 2024 | Common Stock | 20,000 | $105.17 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $590.00 to $590.28, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The option vested in two equal installments on August 29, 2017, and 2020. |